Electrochemical-Based Biosensors: New Diagnosis Platforms for Cardiovascular Disease

Abstract

One of the major reasons for mortality throughout the world is cardiovascular diseases. Therefore, bio-markers of cardiovascular disease are of high importance to diagnose and manage procedure. Detecting biomarkers provided a promising procedure in developing bio-sensors. Fast, selective, portable, accurate, inexpensive, and sensitive biomarker sensing instruments will be necessary for detecting and predicting diseases. One of the cardiac biomarkers may be ordered as C-reactive proteins, lipoprotein-linked phospho-lipase, troponin I or T, myoglobin, interleukin-6, interleukin-1, tumor necrosis factor alpha, LDL and myeloperoxidase. The biomarkers are applied to anticipate cardio-vascular illnesses. Initial diagnoses of these diseases are possible by several techniques; however, they are laborious and need costly apparatus. Current researches designed various bio-sensors for resolving the respective issues. Electrochemical instruments and the proposed bio-sensors are preferred over other methods due to its inexpensiveness, mobility, reliability, repeatability. The present review comprehensively dealt with detecting biomarkers of cardiovascular disease through electro-chemical techniques.

Nanomaterials Responsive to Endogenous Biomarkers for Cardiovascular Disease Theranostics

“…[147][148][149] To better tackle such occult lesions, molecular imaging has been developed to provide an early diagnosis at the molecular level before tissue lesions occur or typical symptoms of CVD are detected. [150][151][152] Among them, nanomaterials as contrast agents for molecular imaging have attracted considerable attention in the last few years; this section presents a systematic overview of the application of nanomaterials as contrast agents in various molecular imaging techniques for CVD diagnosis. A-E) Reproduced with permission.…”

Review of electrochemical and optical biosensors for testosterone measurement

“…In recent years, biosensors have grown enormously regarding their capability in detecting a wide range of biological analytes containing metal ions, proteins, DNA, microorganisms, and so forth, in different samples. [46][47][48] Biosensors are highly sensitive and specific tools for employment in several fields, particularly medicine, the food industry, and pharmacology, making these compact devices an opportunity for investment with billions of dollars market value. 49,50 Generally, to detect the desired molecule, capturing the target and generating a measurable signal are required, which can proceed through biosensing platforms.…”

A review of highly sensitive electrochemical genosensors for microRNA detection: A novel diagnostic platform for neurodegenerative diseases diagnostics

“…4,5 It can be utilized to measure several clinical biomarkers in diagnosis and monitoring stages. 2,[6][7][8] Further, recent studies of altered expression of microRNAs (miRNAs) in several neurological diseases have shown that further effective detection and treatment can be anticipated by tracking the concentration of each as a sensitive biomarker. 9 MiRNAs are a group of short RNAs which have regulatory roles and have opened an innovative window on new individual and therapeutic technologies.…”

“…Thus, optical and electrochemical biosensors are expanding by employing nanomaterials and specific biological agents to detect and track various pathogens 4,5 . It can be utilized to measure several clinical biomarkers in diagnosis and monitoring stages 2,6–8 . Further, recent studies of altered expression of microRNAs (miRNAs) in several neurological diseases have shown that further effective detection and treatment can be anticipated by tracking the concentration of each as a sensitive biomarker 9 .…”